SEC Form 13F

First Turn Management, LLC 13F Holdings

Inspect First Turn Management, LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-15T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-15
Reported value
$934,715,611
Positions
31

Read this manager's filing book

Step 1 of 3

Disclosed positions

First Turn Management, LLC: source evidence dated 2026-08-15T03:59:59.999Z.

Issuer
REVOLUTION MEDICINES INC
Ticker
RVMD
Class
COM
Reported value
$77,778,695
Reported amount
415,307
Unit
SH
Option
None
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

What was reported for this quarter?

13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.

SEC 13F-HR: 0001993440-26-000004
What you should see

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Step 3 of 3

Browse institutional filings

Open the effective filing receipt and inspect shares, value and any put/call classification separately.

Browse institutional filings
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Disclosed positions

See the complete disclosed positions
REVOLUTION MEDICINES INCRVMDCOM$77,778,695415,307SHNone
ABIVAX SAABVXSPONSORED ADS$65,282,608489,889SHNone
AXSOME THERAPEUTICS INC.AXSMCOM$53,461,440218,415SHNone
ENLIVEN THERAPEUTICS INCELVNCOM$48,433,770954,360SHNone
BRIDGEBIO PHARMA INCBBIOCOM$47,172,951633,364SHNone
ROIVANT SCIENCES LTDROIVSHS$47,106,4261,331,066SHNone
UNITED THERAPEUTICS CORP DELUTHRCOM$46,018,70684,932SHNone
CYTOKINETICS INCCYTKCOM NEW$44,930,228527,412SHNone
XENON PHARMACEUTICALS INCXENECOM$36,228,072600,200SHNone
CELCUITY INCCELCCOM$34,430,547329,101SHNone
VIRIDIAN THERAPEUTICS INCVRDNCOM$30,677,9001,670,000SHNone
INSMED INCINSMCOM PAR $.01$28,131,794263,851SHNone
UNIQURE NVQURESHS$28,047,086608,925SHNone
ASCENDIS PHARMA A/SASNDORD SHS$27,972,793104,877SHNone
PRAXIS PRECISION MEDICINES IPRAXCOM NEW$27,964,33983,528SHNone
DIANTHUS THERAPEUTICS INCDNTHCOM$27,856,957285,771SHNone
VAXCYTE INCPCVXCOM$25,800,187443,836SHNone
MIRUM PHARMACEUTICALS INCMIRMCOM$25,527,231218,051SHNone
PALVELLA THERAPEUTICS INC NEPVLACOM$23,908,689156,450SHNone
COGENT BIOSCIENCES INCCOGTCOM$23,308,275602,281SHNone
ERASCA INCERASCOM$22,381,9291,221,721SHNone
ORIC PHARMACEUTICALS INCORICCOM$21,847,1862,017,284SHNone
NEWAMSTERDAM PHARMA COMPANYNAMSORDINARY SHARES$19,740,823582,497SHNone
APOGEE THERAPEUTICS INCAPGECOM$18,425,844138,822SHNone
RHYTHM PHARMACEUTICALS INCRYTMCOM$17,100,619154,018SHNone
INHIBRX BIOSCIENCES INCINBXCOM$15,613,189164,783SHNone
SCHOLAR ROCK HLDG CORPSRRKCOM$14,917,485271,227SHNone
ORUKA THERAPEUTICS INCORKACOM$14,783,993155,343SHNone
KYMERA THERAPEUTICS INCKYMRCOM$11,757,459102,533SHNone
SIONNA THERAPEUTICS INCSIONCOM$4,860,587110,493SHNone
NUVALENT INCNUVLCOM$3,247,80326,298SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.